[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the Food and Drug Administration
September 13, 2000

Nationwide Recall of SangCya Oral Solution

Author Affiliations
 

Not Available

Not Available

JAMA. 2000;284(10):1234. doi:10.1001/jama.284.10.1234-JFD00007-4-1

The FDA has announced nationwide recall of SangCya oral solution (SangStat Medical Corp, Fremont, Calif), a generic version of the antirejection drug cyclosporine (Neoral oral solution). Cyclosporine capsules are not affected.

The FDA asked the sponsor to recall the product because of clinical evidence, recently made available to the agency by SangStat Medical Corp, that the generic drug's availability is low relative to Neoral oral solution when administered with apple juice.

First Page Preview View Large
First page PDF preview
First page PDF preview
×